{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,25]],"date-time":"2026-04-25T02:25:23Z","timestamp":1777083923758,"version":"3.51.4"},"reference-count":93,"publisher":"Hindawi Limited","issue":"4","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1157,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatol Ther"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1111\/j.1529-8019.2012.01514.x","type":"journal-article","created":{"date-parts":[[2012,9,5]],"date-time":"2012-09-05T12:10:59Z","timestamp":1346847059000},"page":"287-296","source":"Crossref","is-referenced-by-count":10,"title":["Classification of vascular disorders in the skin and selected data on new evaluation and treatment"],"prefix":"10.1155","volume":"25","author":[{"given":"Uwe","family":"Wollina","sequence":"first","affiliation":[{"name":"Department of Dermatology and Allergology; Academic Teaching Hospital Dresden-Friedrichstadt; Dresden; Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leonore","family":"Unger","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Division of Rheumatology and Osteology; Academic Teaching Hospital Dresden-Friedrichstadt; Dresden; Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gunter","family":"Haroske","sequence":"additional","affiliation":[{"name":"Institute of Pathology \u201cGeorg Schmorl\u201d; Academic Teaching Hospital Dresden-Friedrichstadt; Dresden; Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgit","family":"Heinig","sequence":"additional","affiliation":[{"name":"Center for Physical and Rehabilitative Medicine; Academic Teaching Hospital Dresden-Friedrichstadt; Dresden; Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"98","published-online":{"date-parts":[[2012,9,5]]},"reference":[{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0001|dth1514-cit-0001","first-page":"1587","volume-title":"Dermatology","author":"Detmar","year":"2003"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0002|dth1514-cit-0002","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1038\/sj.jid.5700464","article-title":"New insights into the molecular control of the lymphatic vascular system and its role in disease","volume":"126","author":"Cueni","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0003|dth1514-cit-0003","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.cps.2004.10.001","article-title":"Current management of hemangiomas and vascular malformations","volume":"32","author":"Marler","year":"2005","journal-title":"Clin Plast Surg"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0004|dth1514-cit-0004","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/MOH.0b013e32832a07ff","article-title":"Signaling mechanisms in infantile hemangioma","volume":"16","author":"Boye","year":"2009","journal-title":"Curr Opin Hematol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0005|dth1514-cit-0005","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10456-009-9148-2","article-title":"Vasculogenesis in infantile hemangioma","volume":"12","author":"Boscolo","year":"2009","journal-title":"Angiogenesis"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0006|dth1514-cit-0006","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1056\/NEJMoa0903036","article-title":"Corticosteroid suppression of VEGF-A in infantile hemangioma-derived stem cells","volume":"362","author":"Greenberger","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0007|dth1514-cit-0007","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1093\/jnci\/95.6.437","article-title":"Effects of interferon alpha on vascular endothelial growth factor gene transcription and tumor angiogenesis","volume":"95","author":"Von Marschall","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0008|dth1514-cit-0008","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.bjps.2010.08.039","article-title":"Expression of components of the renin-angiotensin system in proliferating infantile haemangioma may account for the propranolol-induced accelerated involution","volume":"64","author":"Itinteang","year":"2011","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0009|dth1514-cit-0009","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1089\/153968503322758067","article-title":"Updated classification of haemangiomas and other vascular anomalies","volume":"1","author":"Chang","year":"2003","journal-title":"Lymphat Res Biol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0010|dth1514-cit-0010","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1346-8138.1997.tb02522.x","article-title":"Classification and management of the various superficial vascular anomalies: haemangiomas and vascular malformations","volume":"24","author":"Enjorlas","year":"1997","journal-title":"J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0011|dth1514-cit-0011","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1136\/jcp.2006.038240","article-title":"Histopathological reporting of paediatric cutaneous vascular anomalies in relation to proposed multidisciplinary classification system","volume":"59","author":"Al-Adnani","year":"2006","journal-title":"J Clin Pathol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0012|dth1514-cit-0012","first-page":"461","article-title":"Integrative genomic analyses on HES\/HEY family: notch-independent HES1, HES3, transcription in undifferentiated ES cells, and Notch-dependent HES1, HES5, HEY1, HEY2, HEYL transcription in fetal tissues, adult tissues, or cancer","volume":"31","author":"Katoh","year":"2007","journal-title":"Int J Oncol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0013|dth1514-cit-0013","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10456-009-9161-5","article-title":"A switch in Notch genme expression parallels stem cell to endothelial transition in infantile hemangioma","volume":"13","author":"Wu","year":"2010","journal-title":"Angiogenesis"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0014|dth1514-cit-0014","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/2045-824X-3-19","article-title":"Expression of HES and HEY genes in infantile hemangiomas","volume":"3","author":"Adepoju","year":"2011","journal-title":"Vasc Cell"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0015|dth1514-cit-0015","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1542\/peds.2007-2767","article-title":"Growth characteristics of infantile hemangiomas: implications for management","volume":"122","author":"Chang","year":"2008","journal-title":"Pediatrics"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0016|dth1514-cit-0016","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1097\/PRS.0b013e318208d2ac","article-title":"Untreated hemangiomas: growth pattern and residual lesions","volume":"127","author":"Bauland","year":"2011","journal-title":"Plast Reconstr Surg"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0017|dth1514-cit-0017","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1111\/j.1524-4725.2010.01760.x","article-title":"Combination of oral corticosteroids and polidocanol sclerotherapy in the management of infantile hemangiomas","volume":"36","author":"Grover","year":"2010","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0018|dth1514-cit-0018","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.vph.2010.08.002","article-title":"Propranolol suppresses angiogenesis in vitro: inhibition of proliferation, migration, and differentiation of endothelial cells","volume":"53","author":"Lamy","year":"2010","journal-title":"Vascul Pharmacol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0019|dth1514-cit-0019","doi-asserted-by":"crossref","first-page":"2649","DOI":"10.1056\/NEJMc0708819","article-title":"Propranolol for severe hemangiomas of infancy","volume":"358","author":"Le\u00e1ut\u00e9-Labr\u00e8ze","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0020|dth1514-cit-0020","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2133.2010.09848.x","article-title":"Propranolol for infantile haemangiomas: insights into the molecular mechanisms of action","volume":"163","author":"Storch","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0021|dth1514-cit-0021","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1136\/adc.2010.208884","article-title":"Propranolol for infantile hemangiomas: a review","volume":"96","author":"Strakey","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0022|dth1514-cit-0022","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.jaad.2010.06.048","article-title":"Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants","volume":"65","author":"De Graaf","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0023|dth1514-cit-0023","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.jaad.2010.11.056","article-title":"Atenolol: a promising alternative to propranolol for the treatment of hemangiomas","volume":"65","author":"Rapha\u00ebl","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0024|dth1514-cit-0024","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1111\/j.1525-1470.2005.22318.x","article-title":"Proliferating hemangioma of infancy: successful treatment with topical 5% imiquimod cream","volume":"22","author":"Hazen","year":"2005","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0025|dth1514-cit-0025","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1525-1470.2008.00857.x","article-title":"A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma","volume":"26","author":"McCuaig","year":"2009","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0026|dth1514-cit-0026","first-page":"E21","article-title":"Successful treatment of cutaneous hemangioma of infancy with topical imiquimod 5%: a report of 3 cases","volume":"89","author":"Senchak","year":"2010","journal-title":"Ear Nose Throat J"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0027|dth1514-cit-0027","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1525-1470.2011.01520.x","article-title":"A prospective self-controlled phase II study of imiquimod 5% cream in the treatment of infantile hemangioma","volume":"28","author":"Jiang","year":"2011","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0028|dth1514-cit-0028","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s10456-010-9189-6","article-title":"Targeting NF-\u03baB in infantile hemangioma-derived stem cells reduces VEGF-A expression","volume":"13","author":"Greenberger","year":"2010","journal-title":"Angiogenesis"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0029|dth1514-cit-0029","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s00381-005-1150-4","article-title":"Cutaneous lesions in occult spinal dysraphism - correlation with intraspinal findings","volume":"22","author":"Schropp","year":"2006","journal-title":"Childs Nerv Syst"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0030|dth1514-cit-0030","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1111\/j.1468-3083.2009.03263.x","article-title":"Frequency and phenotypes of cutaneous vascular malformations in a consecutive series of 417 patients with familial cerebral cavernous malformations","volume":"23","author":"Sirvente","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0031|dth1514-cit-0031","doi-asserted-by":"crossref","first-page":"i59","DOI":"10.1136\/ard.2010.138024","article-title":"Pathogenesis of ANCA-associated vasculitides","volume":"70","author":"Kallenberg","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0032|dth1514-cit-0032","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/art.1780330802","article-title":"The American College of Rheumatology 1990 criteria for the classification of vasculitis","volume":"33","author":"Hunder","year":"1990","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0033|dth1514-cit-0033","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/art.1780370206","article-title":"Nomenclature of systemic vasculitides. Proposal of an international consensus conference","volume":"37","author":"Jennette","year":"1994","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0034|dth1514-cit-0034","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2249.2011.04358.x","article-title":"Nomenclature and classification of vasculitis - update on the ACR\/EULAR Diagnosis and Classification of Vasculitis Study (DCVAS)","volume":"164","author":"Luqumani","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0035|dth1514-cit-0035","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0738-081X(99)00058-9","article-title":"Proposal for a working classification of cutaneous vasculitis","volume":"17","author":"Ghersetich","year":"1999","journal-title":"Clin Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0036|dth1514-cit-0036","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/ard.2008.088096","article-title":"EULAR recommendations for the management of primary small and medium vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0037|dth1514-cit-0037","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/ard.2008.088351","article-title":"EULAR recommendations for the management of primary large vessel vasculitis","volume":"68","author":"Mukhtyar","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0038|dth1514-cit-0038","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1007\/s10157-011-0478-1","article-title":"The pathogenesis and treatment of pediatric Henoch-Sch\u00f6nlein purpura nephritis","volume":"15","author":"Kawasaki","year":"2011","journal-title":"Clin Exp Nephrol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0039|dth1514-cit-0039","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1136\/adc.2009.182394","article-title":"Renal manifestations of Henoch-Schonlein purpura in a 6-months prospective study of 223 children","volume":"95","author":"Jauhola","year":"2010","journal-title":"Arch Dis Child"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0040|dth1514-cit-0040","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.25057","article-title":"Long-term efficacy of the interleukin-1 receptor antagonist anakinra in ten patients with neonatal-onset multisystem inflammatory disease\/chronic infantile neurologic, cutaneous, articular syndrome","volume":"62","author":"Neven","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0041|dth1514-cit-0041","first-page":"733","article-title":"Long term management of patients with cryopyrin-associated periodic syndromes (CAPS): focus on rilonacept (IL-1 Trap)","volume":"2","author":"Church","year":"2008","journal-title":"Biologics"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0042|dth1514-cit-0042","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/RHU.0b013e3182288400","article-title":"Refractory urticarial vasculitis as a complication of ulcerative colitis successfully treated with rituximab","volume":"17","author":"Swaminath","year":"2011","journal-title":"J Clin Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0043|dth1514-cit-0043","doi-asserted-by":"crossref","first-page":"191","DOI":"10.2174\/187221308786241910","article-title":"Omalizumab: not only for asthma","volume":"2","author":"Ben-Shoshan","year":"2008","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0044|dth1514-cit-0044","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s11926-010-0130-1","article-title":"Rheumatoid vasculitis: vanishing menace or target for new treatments?","volume":"12","author":"Bartels","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0045|dth1514-cit-0045","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1590\/S1413-86702007000300016","article-title":"Vasculonecrotic reactions in leprosy","volume":"11","author":"Fogagnolo","year":"2007","journal-title":"Braz J Infect Dis"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0046|dth1514-cit-0046","doi-asserted-by":"crossref","first-page":"670","DOI":"10.7326\/0003-4819-150-10-200905190-00004","article-title":"Pulse versus daily oral cyclophosphamide for induction of remission in antineutrophil cytoplasmic antibody-associated vasculitis. A randomized trial","volume":"150","author":"Groot","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0047|dth1514-cit-0047","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1002\/art.27763","article-title":"Improved outcome in 445 patients with Wegener's granulomatosis in a German vasculitis center over four decades","volume":"63","author":"Holle","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0048|dth1514-cit-0048","doi-asserted-by":"crossref","first-page":"31","DOI":"10.5414\/CNP72031","article-title":"Mycophenolate mofetil as maintenance therapy in patients with vasculitis and renal involvement","volume":"72","author":"Iatrou","year":"2009","journal-title":"Clin Nephrol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0049|dth1514-cit-0049","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1136\/ard.2009.109389","article-title":"Early mortality in systemic vasculitis: relative contribution of adverse events and active vasculitis","volume":"69","author":"Little","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0050|dth1514-cit-0050","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1546-0096-9-12","article-title":"Long-term outcome of paediatric patients with ANCA vasculitis","volume":"9","author":"Arulkumaran","year":"2011","journal-title":"Pediatr Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0051|dth1514-cit-0051","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa0909905","article-title":"Rituximab versus cyclophosphamide for ANCA-associated vasculitis","volume":"363","author":"Stone","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0052|dth1514-cit-0052","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1002\/art.24637","article-title":"A multicenter survey of rituximab therapy for refractory antineutrophil cytoplasmic antibody-associated vasculitis","volume":"60","author":"Jones","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0053|dth1514-cit-0053","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000329535","article-title":"Long-term effects of rituximab added to cyclophosphamide in refractory patients with vasculitis","volume":"34","author":"Roccatello","year":"2011","journal-title":"Am J Nephrol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0054|dth1514-cit-0054","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1055\/s-0031-1279825","article-title":"Wegener granulomatosis (granulomatosis with polyangitis): evolving concepts in treatment","volume":"32","author":"Lynch","year":"2011","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0055|dth1514-cit-0055","first-page":"680","article-title":"Rituximab for remission induction and maintenance in ANCA-associated vasculitis: a single-center ten-year experience in 108 patients [abstract]","volume":"62","author":"Cartin-Ceba","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0056|dth1514-cit-0056","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1136\/ard.2010.145250","article-title":"Incidence of malignancy in patients treated for antineutrophil cytoplasm antibody-associated vasculitis: follow-up data from European Vasculitis Study Group clinical trials","volume":"70","author":"Heijl","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0057|dth1514-cit-0057","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1007\/s11926-010-0135-9","article-title":"Giant cell arteritis: epidemiology, diagnosis, and management","volume":"12","author":"Gonzalez-Gay","year":"2010","journal-title":"Curr Rheumatol Rep"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0058|dth1514-cit-0058","first-page":"w13156","article-title":"Rapid induction of remission in large vessel vasculitis by IL-6 blockade","volume":"141","author":"Seitz","year":"2011","journal-title":"Swiss Med Wkly"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0059|dth1514-cit-0059","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1586\/eri.09.109","article-title":"Pathogenesis and management of Kawasaki disease","volume":"8","author":"Rowley","year":"2010","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0060|dth1514-cit-0060","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jpeds.2010.06.014","article-title":"Prospective open-label trial of etanercept as adjunctive therapy for Kawasaki disease","volume":"157","author":"Choueiter","year":"2010","journal-title":"J Pediatr"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0061|dth1514-cit-0061","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1001\/archophthalmol.2011.3","article-title":"Long-term efficacy and safety of low-dose and dose-escalating interferon alfa-2a therapy in refractory Beh\u00e7et uveitis","volume":"129","author":"Onal","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0062|dth1514-cit-0062","doi-asserted-by":"crossref","first-page":"262","DOI":"10.5692\/clinicalneurol.51.261","article-title":"Infliximab treatment trial in a patient with neuro-Beh\u00e7et's disease unresponsive to other treatments] (Japanese)","volume":"51","author":"Kadowaki","year":"2011","journal-title":"Rinsho Shinkeigaku"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0063|dth1514-cit-0063","first-page":"S102","article-title":"Switching to adalumumab is effective in a case of neuro-Beh\u00e7et's disease refractory to infliximab","volume":"28","author":"Lecesse","year":"2010","journal-title":"Clin Exp Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0064|dth1514-cit-0064","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1007\/s10067-011-1805-3","article-title":"A novel cutaneous vasculitis syndrome induced by levamisole-contaminated cocaine","volume":"30","author":"Gross","year":"2011","journal-title":"Clin Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0065|dth1514-cit-0065","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1111\/j.1468-3083.2010.03803.x","article-title":"Aromatase inhibitor-induced skin adverse reactions: exemestane-related cutaneous vasculitis","volume":"25","author":"Santoro","year":"2011","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0066|dth1514-cit-0066","first-page":"2287","article-title":"Anti-tumor necrosis factor-\u03b1 therapy-induced vasculitis: case series","volume":"30","author":"Jarrett","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0067|dth1514-cit-0067","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1111\/j.1365-2133.2007.07682.x","article-title":"Cutaneous side-effects in patients with rheumatic diseases during application of tumour necrosis factor-\u03b1 antagonists","volume":"156","author":"Lee","year":"2007","journal-title":"Br J Dermatol"},{"issue":"Suppl. 3","key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0068|dth1514-cit-0068","first-page":"548","article-title":"Drug survival and safety of tocilizumab in comparison to TNF inhibitors, including use as second biologic agent [abstract]","volume":"69","author":"Yoshida","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0069|dth1514-cit-0069","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1365-2133.1964.tb14499.x","article-title":"The \u201cyellow nail\u201d syndrome","volume":"76","author":"Samman","year":"1964","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0070|dth1514-cit-0070","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4103\/0022-3859.58931","article-title":"Yellow nail syndrome following thoracic surgery: a new association?","volume":"55","author":"Banta","year":"2009","journal-title":"J Postgrad Med"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0071|dth1514-cit-0071","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1200\/JCO.2010.31.8402","article-title":"Lung cancer in association with yellow nail syndrome","volume":"29","author":"Carnassale","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0072|dth1514-cit-0072","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1378\/chest.08-0137","article-title":"Yellow nail syndrome. Analysis of 41 consecutive patients","volume":"134","author":"Maldonado","year":"2008","journal-title":"Chest"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0073|dth1514-cit-0073","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1529-8019.2010.01371.x","article-title":"Diagnosis and treatment of cutaneous paraneoplastic disorders","volume":"23","author":"Abreu Velez","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0074|dth1514-cit-0074","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/j.1365-4632.2005.02066.x","article-title":"Improvement in lymphatic function and partial resolution of nails after complex decongestive physiotherapy in yellow nail syndrome","volume":"44","author":"Szolnoky","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0075|dth1514-cit-0075","first-page":"276","article-title":"Combination of fluconazole and alpha-tocopherol in the treatment of yellow nail syndrome","volume":"8","author":"Baran","year":"2009","journal-title":"J Drugs Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0076|dth1514-cit-0076","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1111\/j.1525-1470.2010.01338.x","article-title":"Yellow nail syndrome","volume":"27","author":"Al Hawsawi","year":"2010","journal-title":"Pediatr Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0077|dth1514-cit-0077","first-page":"99","article-title":"Yellow nail syndrome in a medical clinic","volume":"60","author":"Iheonunekwu","year":"2011","journal-title":"West Indian Med J"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0078|dth1514-cit-0078","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.2169\/internalmedicine.46.0022","article-title":"Idiopathic yellow nail syndrome successfully treated with OK-432","volume":"46","author":"Yamagishi","year":"2007","journal-title":"Intern Med"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0079|dth1514-cit-0079","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/j.1752-699X.2007.00022.x","article-title":"Yellow nail syndrome: treatment with octreotide","volume":"1","author":"Hillerdal","year":"2007","journal-title":"Clin Respir J"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0080|dth1514-cit-0080","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1111\/j.1365-4632.2009.04226.x","article-title":"Cutaneous lymphangioma circumscriptum: frog spawn on the skin","volume":"48","author":"Patel","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0081|dth1514-cit-0081","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/j.lpm.2010.09.007","article-title":"[Localized cystic lymphatic malformation (or cutaneous lymphangiomas)] (French)","volume":"39","author":"Lorette","year":"2010","journal-title":"Presse Med"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0082|dth1514-cit-0082","first-page":"852","article-title":"Dermoscopic features of cutaneous lymphangioma circumscriptum","volume":"32","author":"Arpaia","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0083|dth1514-cit-0083","first-page":"147","article-title":"Massive cavernous lymphangioma of the breast and thoracic wall: case report and literature review","volume":"39","author":"Krainick-Strobel","year":"2006","journal-title":"Lymphology"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0084|dth1514-cit-0084","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/j.1365-2133.2010.09869.x","article-title":"Cutaneous lymphangioma as a diagnostic clue for thoracic lymphangiomatosis","volume":"163","author":"Bae","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0085|dth1514-cit-0085","first-page":"1451","article-title":"Treatment of unusual vascular lesions: usefulness of sclerotherapy in lymphangioma circumscriptum and acquired arteriovenous malformation","volume":"31","author":"Park","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0086|dth1514-cit-0086","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1017\/S0022215107001132","article-title":"Adult cystic hygroma: successful use of OK-432 (Picibanil)","volume":"122","author":"Woolley","year":"2008","journal-title":"J Laryngol Otol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0087|dth1514-cit-0087","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijporl.2004.08.008","article-title":"Bleomycin sclerotherapy in congential lymphatic and vascular malformations of head and neck","volume":"69","author":"Mathur","year":"2005","journal-title":"Int J Pediatr Otorhinolaryngol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0088|dth1514-cit-0088","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1089\/lrb.2008.1004","article-title":"Percutaneous sclerotherapy of lymphatic malformations with doxycycline","volume":"6","author":"Burrows","year":"2008","journal-title":"Lymphat Res Biol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0089|dth1514-cit-0089","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.jpedsurg.2006.10.012","article-title":"Treatment of lymphangioma in children: our experience of 128 cases","volume":"42","author":"Okazaki","year":"2007","journal-title":"J Pediatr Surg"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0090|dth1514-cit-0090","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4103\/0019-5154.77558","article-title":"Lymphangioma circumscriptum treated with radiofrequency ablation","volume":"56","author":"Sachdeva","year":"2011","journal-title":"Indian J Dermatol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0091|dth1514-cit-0091","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1111\/j.1524-4725.2010.01723.x","article-title":"Microcystic lymphatic malformation (lymphangioma circumscriptum) treated using a minimally invasive technique of radiofrequency ablation and sclerotherapy","volume":"36","author":"Niti","year":"2010","journal-title":"Dermatol Surg"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0092|dth1514-cit-0092","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1089\/lrb.2006.4.101","article-title":"CO2 laser ablation of lymphangioma circumscriptum of the scrotum","volume":"4","author":"Treharne","year":"2006","journal-title":"Lymphat Res Biol"},{"key":"10.1111\/j.1529-8019.2012.01514.x-BIB1514-bib-0093|dth1514-cit-0093","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1524-4725.2011.01914.x","article-title":"Acquired scrotal lymphangioma successfully treated using carbon dioxide laser ablation","volume":"37","author":"Lanjouw","year":"2011","journal-title":"Dermatol Surg"}],"container-title":["Dermatologic Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1529-8019.2012.01514.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1529-8019.2012.01514.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T17:58:59Z","timestamp":1671818339000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1529-8019.2012.01514.x"}},"subtitle":["Vascular disorders"],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":93,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,7]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1529-8019.2012.01514.x","relation":{},"ISSN":["1396-0296"],"issn-type":[{"value":"1396-0296","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}